Contact RegMed XB

Stichting REGenerative MEDicine Crossing Borders
📞 +3188 388 7050

Minderbroedersberg 4-6, 6211 LK Maastricht
Chamber of Commerce: 67539408

RegMed XB vzw (Flanders)
Waaistraat 6, 3000 Leuven
Chamber of Commerce: 0787588431

Visiting Addresses

Beatrixgebouw (fifth floor)
Jaarbeursplein 6
3521 AL Utrecht, The Netherlands

Maastricht University (third floor)
Universiteitssingel 40
6229 ER Maastricht, The Netherlands

Bio-incubator 4 (third floor)
Gaston Geenslaan 3 
3001 Leuven, Belgium

For specific questions about the Moonshots, contact the corresponding health foundations:

• Cardiovascular Moonshot, contact the Dutch Heart Foundation
• Diabetes Moonshot, contact the Diabetes Fonds or Stichting DON
• Eye Moonshot, contact the Oogfonds
• Kidney Moonshot, contact the Nierstichting
• Osteoarthritis Moonshot, contact ReumaNederland

RegMed XB has a growth model with an undefined range. The pioneering nature of the research makes this necessary; the determination of the partners makes it possible. In the first five years, we started with the four Moonshots, but over time new research projects can start. The number of partners and the budget will grow further.

RegMed XB aims to be the leading European institute of regenerative medicine and will be a worldwide renowned valorization institute in RM. Research into complex diseases will never be finished and does not stop at the border. It is our dream to align the initiatives worldwide into the relevant disease areas. This way each country will do what they do best but we ensure a coordinated effort to cure chronic disease. In the future, partnerships with other very large and successful regenerative medicine hot spots such as in Boston and California are also obvious.

We are beginning with the Netherlands and Flanders as they have an excellent record of research in regenerative medicine for many years. By combining their strengths in the scope and high quality of research and the smart business way of working. If you are interested to join RegMed XB as a (foreign) region, country or initiative; please do reach out to us via This email address is being protected from spambots. You need JavaScript enabled to view it.

RegMed XB brings together health foundations, scientists, patients, entrepreneurs, and governments to cooperatively tackle ambitious challenges in regenerative medicine. The development of therapies based on regenerative medicine has a tremendous societal impact as the aim is on cure instead of care. This implies bettering the lives of millions and at the same time preventing lifelong, expensive care processes. To work towards successful therapies using regenerative medicine, RegMed XB is patient-driven on various levels throughout the research projects. Expert patients are present at the semi-annual progress meetings and follow and contribute to discussions about the research process. External patients are asked to review the project plans and evaluate if the scientific direction is aligned with the most pressing patient needs. In addition, there is a yearly event at which researchers inform the general public on what the current status of the research is including successes and set-backs. There is also the opportunity to ask questions or voice possible concerns.

Besides an active role in the Moonshots, we are happy to have patient representation also present in the governance of RegMed XB. Specifically a patient Advocate in the Board of Directors and a patient representation seat in the Supervisory board.

The patient will remain a key voice in RegMed XB starting from the earliest steps in the Moonshots towards the first clinical trials.RegMed XB firmly believes that the involvement of the patient at an early stage of research will increase the viability of therapies that the researchers are working on. A researcher is mainly focused on the efficacy, effectiveness, and quality of therapy, whereas the patient has ideas on the actual implications and consequences of therapy on their life. Bringing these ideas together will improve the overall quality of the development of therapies.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse vel velit vestibulum, imperdiet tortor vel, suscipit enim. Proin quis ornare nisl. Cras eu mi hendrerit, fermentum sapien eu, finibus eros. Donec felis ante, molestie id mauris sed, tincidunt efficitur massa. Vivamus egestas neque quam, non rhoncus ex mattis a. Aliquam ac lacus varius ipsum volutpat interdum. Sed posuere, purus eget tempor tempor, est sem suscipit magna, a sodales erat libero nec massa. Nunc vitae odio ipsum. Integer porta efficitur elit nec gravida. In auctor metus velit, eu vestibulum tellus convallis ut. Nam eget enim eu magna venenatis viverra vitae sit amet enim.

Phasellus sit amet lectus vel dui egestas tincidunt. Cras in imperdiet urna. Donec commodo diam quis scelerisque luctus. Curabitur ac velit quis est bibendum posuere vel ac mi. Ut tempor, libero sed ornare rhoncus, purus orci laoreet orci, vitae sollicitudin ex sapien non tortor. Morbi eu dictum nisi. Nunc ultricies, lectus vel commodo viverra, orci metus tristique diam, id blandit diam metus vitae turpis. Vestibulum consectetur lectus eu sapien blandit, mollis aliquam diam ultricies. Sed fermentum id ex ac mattis. Donec libero sem, fringilla sit amet volutpat semper, ultricies a tortor. Aenean eu mollis felis. Nam ac orci lorem.

In sapien sem, mollis eu porttitor id, porttitor sed velit. Aenean quis ultricies dui, in posuere enim. In vel diam facilisis, semper mauris quis, vehicula nulla. Maecenas elementum felis sed tellus sagittis egestas. Proin convallis aliquet eleifend. Morbi ac mauris nec felis tincidunt viverra quis eget mi. Nunc vel aliquet mauris. Donec libero justo, scelerisque id mi ut, tempus commodo dui.

Proin laoreet augue et neque eleifend, a consequat dolor tempus. Proin porta quam massa, id iaculis libero elementum vel. Maecenas molestie aliquet velit, nec congue sapien varius a. Morbi quis nibh ex. Aenean vitae purus elementum, luctus elit vel, lacinia erat. Aenean in augue volutpat, gravida arcu quis, sodales augue. Quisque imperdiet pulvinar interdum. Quisque laoreet et mi sit amet convallis. Donec eget sagittis erat.